What is the classification of deutetrabenazine?
•
2 min read
Deutetrabenazine, first approved by the FDA in 2017, is primarily classified as a vesicular monoamine transporter 2 (VMAT2) inhibitor. This medication, known by the brand names Austedo and Austedo XR, is a specifically modified version of the older drug tetrabenazine, designed for improved pharmacokinetics.
